It added, “The foregoing revision is made pursuant to the discretionary power of the FDA… to revisit any issued EUA as may be appropriate to protect the general public health and safety.”
The Philippines has just breached the 6 million mark of administered COVID-19 vaccine doses – 1.3 million health workers, 1.5 million seniors, 1.4 million adults with comorbidities, and around 12,200 workers.
Vaccine recipients are all part of predetermined priority groups that, despite the amendment to the Pfizer EUA, continues to be followed.
“While we welcome more vaccines that are approved for children and adolescents, due to limited vaccine supply, our vaccination strategy remains the same — prioritize the vulnerable and adhere to our prioritization framework,” said health Undersecretary Rosario Vergeire.
“The general consensus of our vaccine experts is to revisit pediatric and adolescent vaccination once our vaccine supply has stabilized.”
Vaccine deliveries got off to a rough start but has begun to come more regularly. The Philippines expects to receive another 4.5 million doses of Sinovac, 100,000 doses of Sputnik V, 2 million doses of Pfizer, and 250,000 doses of Moderna within the month.
In a report to the Cabinet on Monday night, Secretary Carlito Galvez raised the possibility of Filipino children receiving the jab, “citing ongoing studies or approvals of vaccine brands Sinovac, Pfizer, and Moderna” as well as 11 other vaccine brands.
ADVERTISEMENT - CONTINUE READING BELOW
"We have anticipated the pediatric vaccination...The population (of that sector) is about 39 million," Galvez said in a separate press briefing.
He added, “The implication of that is we need to buy more vaccines, more or less 60 million (doses).”
Galvez believes that inoculating the country’s 29 million school-age children “will pave the way for the reopening of face-to-face classes.”